🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Analysis of the Incidence and Risk Factors of Chronic Pain After Cesarean Section

Recruitingn/aAges 20 Years - 50 YearsFemaleHuazhong University of Science and Technology
NCT06704490 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Persistent postoperative pain is a globally recognized issue that deserves attention. Cesarean section is one of the surgeries that may cause persistent postoperative pain. PSPP may affect communication between mother and baby, and may lead to postpartum depression, which has a negative impact on the daily activities and quality of life of mothers. It is an important clinical issue. The main purpose of this study is to (1) prospectively investigate the overall incidence and characteristics of persistent pain after cesarean section at 3, 6, and 12 months after surgery; (2) Use regression analysis and data modeling analysis to evaluate the relationship between perioperative variables and chronic pain in postpartum women undergoing cesarean section; (3) Analyze the relationship between chronic pain after cesarean section and postpartum depression in postpartum women.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age range from 20 to 50 years old; * ASA grades I to III; * Full term pregnancy and planned cesarean section with transverse incision in the lower segment of the uterus; * Pregnant women who are willing to participate in this study and sign informed consent forms. Exclusion Criteria: * Have a history of dementia, mental illness, or any central nervous system disorder; * Pregnant women who are addicted to alcohol and drugs; * Difficulty in follow-up or poor patient compliance; * Has taken other investigational drugs or participated in other clinical trials in the three months prior to being selected for the study; * Serious complications occur during delivery; * Unable to cooperate with the research for any reason.
💊

What it tests

  • Cesarean section
📍

Where

1 site
Tongji hospital
Wuhan, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy